in-PharmaTechnologist presents its round up of the latest comings and going within the pharmaceutical industry, including news from SPBT, Viamet and Virobay.
Greater FDA oversight of US manufacturing plants increased the number of drug recalls in Q3 in a trend that is likely to continue according to a new report.
Piramal Healthcare has added commercial-scale antibody-drug-conjugate (ADC) manufacturing capacity at its UK plant predicting increasing demand for this specialist type of contracting.
Gains made in manufacturing, particularly in biologics, were pegged back by the impact raw materials costs and the strong Franc had on its ingredients division says Lonza.
Quintiles says it will buy US bioanalytical lab Advion BioServices citing a pharmaceutical industry shift towards more thorough laboratory testing as motivation.
API manufacturers will contribute a fraction of the annual fee paid to the US FDA if the proposed generic drug user fee act (GDUFA) is passed by Congress next year
A new antiretroviral (ARV) transdermal delivery patch developed at ImQuest Biosciences will wipe out the need for the “cocktail” of oral medication HIV sufferers have to take every day.
Retrofitting stainless steel plants with single-use systems is driving a “paradigm shift” in drug production but creates logistical problems, an AAPS panel said.
Outsourcing-Pharma presents its round-up of the latest appointments within the pharmaceutical industry, inclduign news from Novella, Roche, and Nycomed.
Multinational biotech giant, Lonza, has completed the acquisition of US-based Arch Chemicals as the company bids to tap into the microbial control sector.
Drug giant GlaxoSmithKline (GSK), contract research organisation (CRO) Medpace, and institutional review board Quorum Review IRB have all been honoured with Eagle awards at this year's Site Solutions Summit, held in Ellicott City, Maryland, USA.
in-PharmaTechnologist presents its round-up of the latest appointments within the pharmaceutical industry, including news from Novocure, YM BioSciences, and SGVI.
Industry groups developing certification standards for third-party auditors of pharmaceutical excipient manufacturers say they are ready to launch the scheme next year.
Almac hopes adding high potency API manufacturing capacity at its plant in Craigavon, Northern Ireland will help it retain early phase projects as they move to late-stage development.
Fine chemicals manufacturer Saltigo is looking to expand its high potency API (HPAPI) business by targeting the pharmaceutical industry in the US and Japan.
Carbogen Amcis has signed a strategic deal with formulations specialist Polymun Scientific in a agreement designed to support the development of its high potency manufacturing business.
Quintiles has bought its way into the observational research space with the acquisition of Outcome Sciences and strengthened its market access standing with the purchase of VCG & Associates.